Posaconazole-camberlogo1 (Posaconazole Camberlogo1)
Posaconazole Tablet, Delayed Release
Product Images NDC 31722-677
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 31722-677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Posaconazole-camberlogo2 (Posaconazole Camberlogo2)
Posaconazole-containerlabel (Posaconazole Containerlabel)
This is a description of a prescription drug named Posaconazole in its delayed-release tablet form. It includes the NDC number, dosage information, and storage recommendations. The text also notes that Noxafil oral suspension and Posaconazole delayed-release tablets differ in dosing and cannot be used interchangeably. The medication is manufactured by Camber Pharmaceuticals in New Jersey, with batch coding done by Hetero Labs Limited in India. The page contains a patient information source and a US contact number for the medication.*
Posaconazole-structure (Posaconazole Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
